Roles Played by Chemolipiodolization and Embolization in Chemoembolization for Hepatocellular Carcinoma: Single-Blind, Randomized Trial-Reference-Cited by-全球学者库

Roles Played by Chemolipiodolization and Embolization in Chemoembolization for Hepatocellular Carcinoma: Single-Blind, Randomized Trial

Published:2012-11-12 Issue:1 Volume:105 Page:59-68
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Shi Ming,Lu Li-Gong,Fang Wan-Qiang,Guo Rong-Ping,Chen Min-Shan,Li Yong,Luo Jun,Xu Li,Zou Ru-Hai,Lin Xiao-Jun,Zhang Ya-Qi

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/105/1/59/17312221/djs464.pdf

Reference33 articles.

1. Management of hepatocellular carcinoma;Bruix;Hepatology,2005

2. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial;Llovet;Lancet,2002

3. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma;Lo;Hepatology,2002

4. Association between vascular endothelial growth factor and metastasis after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma;Xiong;Hepatobiliary Pancreat Dis Int,2004

5. Sequential transarterial chemoembolization for unresectable advanced hepatocellular carcinoma;Jaeger;Cardiovasc Intervent Radiol,1996

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of GNMT and MMP12 Expression in Determining TACE Efficacy: Validation at Transcription and Protein Levels;Journal of Hepatocellular Carcinoma;2024-01

2. Association of hepatitis B virus DNA levels with efficacy and safety outcomes in patients with hepatitis B virus-associated advanced hepatocellular carcinoma receiving tyrosine kinase inhibitor plus anti-PD-1 antibody: a multicenter propensity-matched study;International Immunopharmacology;2023-12

3. Comparable Clinical Outcomes Between Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy Combined with Tyrosine Kinase Inhibitors and PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma;Journal of Hepatocellular Carcinoma;2023-10

4. Modified Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and Camrelizumab for Advanced HCC: Two Case Reports;Journal of Hepatocellular Carcinoma;2023-09

5. A Randomized Comparison of Transradial and Transfemoral Approach in Hepatic Arterial Infusion Chemotherapy;Current Medical Imaging Formerly Current Medical Imaging Reviews;2023-07-07